NEW YORK (GenomeWeb News) – Under an agreement announced today, Courtagen Life Sciences will incorporate SimulConsult's Genome-Phenome Analyzer into its process for the clinical interpretation of genetic tests.

The Genome-Phenome Analyzer is software that allows researchers to combine a genome variant table with the phenotypic data entered by a clinician "thereby using the full power of genome [and] phenome to arrive at a diagnosis in seconds," SimulConsult said on its website.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.